Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Eli Lilly and Company (LLY): A Bull Case Theory
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...
pharmaphorum23h
5 takeaways from Super Bowl LIX: What health and pharma can learn from it
Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...
STAT23h
Vertex pain pill dominates earnings call discussion
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Biogen receives Market Perform rating at Bernstein ahead of earnings
Biogen (BIIB) stock was granted a Market Perform recommendation by Bernstein ahead of Q4 earnings, citing concerns over its Alzheimer's drug sales. Read more here.
Investing3h
These two stocks are Morgan Stanley's "top picks" in the European pharma sector
Investing.com - European pharmaceutical stocks offer solid growth, valuations near 10-year lows, and a possible safe haven ...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Indiatimes12h
Gold Rate Today in India
Why is it important to know how much gold costs right now?